FIELD: organic chemistry, pharmacy. SUBSTANCE: invention relates to morphinane O-aryl esters of the general formula (IA) where R2′ is free or substituted pyridyl, thiazolyl, thienyl, phenyl or a group of the formula ; R20 is H, alkyl or a group R1′ where one of Y and C(Y,Y1)-CH2OH is H and other alkyl, or both Y and Y1 are alkyls at condition that when Y1 is pyridyl or R2′ phenyl then R1′ can not be alkyl, or their pharmaceutical salts. Compounds of the formula (IA) decrease unwanted effect of neurotoxic damage and therefore they can be used for treatment of patients with convulsions and neuroinhereted sicknesess. EFFECT: improved method of synthesis, enhanced effectiveness of compounds.
Authors
Dates
1998-12-10—Published
1993-12-28—Filed